Wilmington, DE, United States of America

Richard Alan Keith

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Astrazeneca Ab, Astrazenela UK Limited. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Alan Keith. Retrieved from https://idiyas.com/inventor/richard-alan-keith

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovations of Richard Alan Keith: A Pioneer in Pharmaceutical Advancements**

Introduction

Richard Alan Keith, an accomplished inventor based in Wilmington, Delaware, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Keith’s innovative approaches have focused on developing compounds and methods that address critical medical needs.

Latest Patents

Among his most notable patents is a groundbreaking work on ligands—radioactive compounds designed for various medical applications. This patent encompasses not just the compounds themselves, but also their pharmaceutically acceptable salts, enantiomers, and in vivo-hydrolysable precursors. Furthermore, it details pharmaceutical compositions and formulations containing these compounds, methods for treating diseases and conditions, as well as analytical uses. Keith's work has the potential to advance treatments for a variety of health conditions, showcasing his commitment to addressing pressing medical challenges.

Another significant patent pertains to a method for treating neurological disorders, demonstrating his focus on addressing complex health issues that affect countless individuals.

Career Highlights

Throughout his career, Richard Alan Keith has worked with influential companies in the pharmaceutical sector, including AstraZeneca AB and AstraZeneca UK Limited. His position at these esteemed organizations has enabled him to be at the forefront of pharmaceutical research and development, contributing innovative solutions that aim to enhance patient outcomes.

Collaborations

Keith has collaborated with notable professionals, including Timothy Piser and Michael Thaddeus Klimas. These partnerships reflect his commitment to teamwork and collaborative innovation, further driving advances in pharmaceutical science through shared expertise and diverse perspectives.

Conclusion

Richard Alan Keith stands out as a prominent inventor whose work has substantially influenced the pharmaceutical industry. His patents represent not only innovative technologies but also a dedication to improving healthcare. As he continues to develop new methodologies and compounds, Richard Alan Keith remains a crucial figure in the innovation landscape of medical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…